Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography

Journal of Clinical Oncology

Volumn 26, Issue 9, 2008, Pages 1489-1495

  Koopmans, Klaas P ^a   Neels, Oliver C ^a   Kema, Ido P ^a   Elsinga, Philip H ^a   Sluiter, Wim J ^a   Vanghillewe, Koen ^a   Brouwers, Adrienne H ^a   Jager, Pieter L ^a   De Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN C 11; DIHYDROXYPHENYLALANINE F 18; IODIXANOL; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR; TRACER; UNCLASSIFIED DRUG; 5 HYDROXYTRYPTOPHAN; CARBON; DIAGNOSTIC AGENT; DOPA; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CARCINOID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PANCREAS ISLET CELL TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; COMPARATIVE STUDY; EVALUATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PANCREAS TUMOR; RADIOGRAPHY; SCINTISCANNING;

5-HYDROXYTRYPTOPHAN; ADENOMA, ISLET CELL; ADULT; AGED; CARBON RADIOISOTOPES; CARCINOID TUMOR; DIHYDROXYPHENYLALANINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41149124919     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.1126     Document Type: Article

References (28)

1. Pearse AG: The APUD cell concept and its implications in pathology. Pathol Annu 9:27-41, 1974
2. Moertel CG, Lefkopoulo M, Lipsitz S, et al: Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 326:519-523, 1992
3. Modlin IM, Kidd M, Latich I, et al: Current status of gastrointestinal carcinoids. Gastroenterology 128:1717-1751, 2005
4. Plöckinger U, Rindi G, Arnold R, et al: Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors: A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80:394-424, 2004
5. Koopmans KP, de Vries EG, Kema IP, et al: Staging of carcinoid tumours with 18F-DOPA PET: A prospective, diagnostic accuracy study. Lancet Oncol 7:728-734, 2006
6. Hoegerle S, Altehoefer C, Ghanem N, et al: Whole-body 18F DOPA PET for detection of gastrointestinal carcinoid tumours. Radiology 220:373-380, 2001
7. Kumbasar B, Kamel IR, Tekes A, et al: Imaging of neuroendocrine tumours: Accuracy of helical CT versus SRS. Abdom Imaging 29:696-702, 2004
8. de Herder WW, Hofland LJ, van der Lely AJ, et al: Somatostatin receptors in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 10:451-458, 2003
9. Fahey FH, Harkness BA, Keyes JW, Jr., et al: Sensitivity, resolution and image quality with a multihead SPECT camera. J Nucl Med 33:1859-1863, 1992
10. Becherer A, Szabo M, Karanikas G, et al: Imaging of advanced neuroendocrine tumours with (18)F-FDOPA PET. J Nucl Med 45:1161-1167, 2004
11. Meijer WG, Copray SC, Hollema H, et al: Catecholamine-synthesizing enzymes in carcinoid tumours and pheochromocytomas. Clin Chem 49:586-593, 2003
12. Bjurling P, Watanabe Y, Tokushige M, et al: Synthesis of b-11C-labelled L-tryptophan and 5-hydroxy-L-tryptophan using a multi-enzymatic reaction route. J Chem Soc 1331-1334, 1981
13. Orlefors H, Sundin A, Garske U, et al: Wholebody (11)C-5- hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumours: Comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 90:3392-3400, 2005
14. [11C]-5-hydroxy-L-tryptophan on a Zymark robotic system. J Labelled Comp Radiopharm 49:889-895, 2006
15. Bergstrom M, Lu L, Eriksson B, et al: Modulation of organ uptake of 11C-labelled 5-hydroxytryptophan. Biog Amines 12:477-485, 1996
16. Orlefors H, Sundin A, Lu L, et al: Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with (11)C-5- hydroxytryptophan positron emission tomography. Eur J Nucl Med Mol Imaging 33:60-65, 2006
17. Vries EFJ, Luurtsema G, Brussermann M, et al: Fully automated synthesis module for the high yield one-pot preparation of 6-[18F]-fluoro-L-DOPA. Appl Radiat Isot 51:389-419, 1999
18. Brown WD, Oakes TR, DeJesus OT, et al: Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment. J Nucl Med 39:1884-1891, 1998
19. International Commission on Radiological Protection: ICRP publication 80: radiation dose to patients from radiopharmaceuticals. Oxford, United Kingdom, Elsevier, 2000
20. Balon HR, Goldsmith SJ, Siegel BA, et al: Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med 42:1134-1138, 2001
21. International Commission on Radiological Protection: ICRP publication 87: Managing patient dose in computed tomography. http://www.icrp.org
22. Kema IP, Schellings AM, Hoppenbrouwers CJ, et al: High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients. Clin Chim Acta 221:143-158, 1993
23. Kema IP, Meiborg G, Nagel GT, et al: Isotope dilution ammonia chemical ionization mass fragmentographic analysis of urinary 3O-methylated catecholamine metabolites: Rapid sample clean-up by derivatization and extraction of lyophilic samples. J Chromatogr 617:181-189, 1993
24. Kema IP, Meijer WG, Meiborg G, et al: Profiling of tryptophan-related plasma indoles in patients with carcinoid tumours by automated, on-line, solid-phase extraction and HPLC with fluorescence detection. Clin Chem 47:1811-1820, 2001
25. Willemsen JJ, Ross HA, Wolthers BG, et al: Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. Ann Clin Biochem 38:722-730, 2001
26. Bossuyt PM, Reitsma JB, Bruns DE, et al: Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Standards for reporting of diagnostic accuracy. Clin Chem 49:1-6, 2003
27. Smith CC: Evidence for separate serotonin and catecholamine compartments in human platelets. Biochim Biophys Acta 1291:1-4, 1996
28. Mohnike K, Blankenstein O, Christesen HT, et al: Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism. Horm Res 66:40-42, 2006